KSQ Trademark

Trademark Overview


On Thursday, January 19, 2023, a trademark application was filed for KSQ with the United States Patent and Trademark Office. The USPTO has given the KSQ trademark a serial number of 97761284. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, April 1, 2025. This trademark is owned by KSQ Therapeutics, Inc.. The KSQ trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals for use in the treatment of cancer and autoimmune disease containing small molecules; cells for medical use; pharmaceuticals for use in the treatment of cancer and autoimmune disease

Cells for scientific and research use

Medical and scientific research in the field of cell therapies, biotechnology, and drug development; providing medical and scientific research information; research and development in the field of cell therapies, biotechnology, and drug development; drug discovery services; laboratory research services relating to pharmaceuticals; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields

General Information


Serial Number97761284
Word MarkKSQ
Filing DateThursday, January 19, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, April 1, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 1, 2025

Trademark Statements


Description of MarkThe mark consists of the stylized letters "KSQ", where the "Q" appears as a circular arrow and each letter is divided in half vertically.
Goods and ServicesPharmaceuticals for use in the treatment of cancer and autoimmune disease containing small molecules; cells for medical use; pharmaceuticals for use in the treatment of cancer and autoimmune disease
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesCells for scientific and research use
Goods and ServicesMedical and scientific research in the field of cell therapies, biotechnology, and drug development; providing medical and scientific research information; research and development in the field of cell therapies, biotechnology, and drug development; drug discovery services; laboratory research services relating to pharmaceuticals; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, February 9, 2023
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 9, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, February 9, 2023
Primary Code042
First Use Anywhere DateMonday, October 2, 2017
First Use In Commerce DateMonday, October 2, 2017

Trademark Owner History


Party NameKSQ Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Party NameKSQ Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Trademark Events


Event DateEvent Description
Tuesday, October 17, 2023NON-FINAL ACTION E-MAILED
Monday, January 23, 2023NEW APPLICATION ENTERED
Thursday, February 9, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 10, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, October 17, 2023ASSIGNED TO EXAMINER
Tuesday, October 17, 2023NON-FINAL ACTION WRITTEN
Tuesday, October 17, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 16, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 16, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 17, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 29, 2024NON-FINAL ACTION WRITTEN
Monday, January 29, 2024NON-FINAL ACTION E-MAILED
Monday, January 29, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 24, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 24, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 24, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 1, 2024NON-FINAL ACTION E-MAILED
Monday, July 1, 2024NON-FINAL ACTION WRITTEN
Monday, July 1, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 25, 2024FINAL REFUSAL E-MAILED
Monday, September 30, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 30, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 1, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 25, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, November 25, 2024FINAL REFUSAL WRITTEN
Monday, February 10, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 10, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 10, 2025TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, February 10, 2025EXPARTE APPEAL RECEIVED AT TTAB
Monday, February 10, 2025JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, February 10, 2025EX PARTE APPEAL-INSTITUTED
Thursday, March 6, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 6, 2025EXPARTE APPEAL TERMINATED
Wednesday, March 26, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 1, 2025PUBLISHED FOR OPPOSITION
Tuesday, April 1, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED